Characterisation of a rat model of pulmonary arterial hypertension

Hellenic Journal of Cardiology

Volumn 48, Issue 4, 2007, Pages 206-210

  Kolettis, Theofilos ^a   Vlahos, Antonios P ^a   Louka, Maria ^a   Hatzistergos, Konstantinos E ^a   Baltogiannis, Giannis G ^a   Agelaki, Maria M ^a   Mitsi, Agathokleia ^a   Malamou Mitsi, Vassiliki ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Endothelin; Pressure recordings; Pulmonary hypertension; Rat

Indexed keywords

ENDOTHELIN B RECEPTOR; MONOCROTALINE; ENDOTHELIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEMODYNAMICS; HISTOPATHOLOGY; MORTALITY; NONHUMAN; PULMONARY HYPERTENSION; RAT; RESPIRATORY ARREST; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD PRESSURE MEASUREMENT; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; FEASIBILITY STUDY; FEMALE; MALE; METHODOLOGY; PATHOPHYSIOLOGY; THORACOTOMY;

ANIMALS; BLOOD PRESSURE DETERMINATION; DISEASE MODELS, ANIMAL; ENDOTHELIN-2; FEASIBILITY STUDIES; FEMALE; HYPERTENSION, PULMONARY; MALE; MONOCROTALINE; RATS; THORACOTOMY;

EID: 34848815625     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Newman JH: Pulmonary hypertension. Am J Respir Crit Care Med 2005; 172: 1072-1077.
2. Rabinovitch M: Cellular and molecular pathobiology of pulmonary hypertension conference summary. Chest 2005; 128: 642S-646S.
3. Simonneau G, Galie N, Rubin LJ, et al: Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43: 5S-12S.
4. Rich S: The current treatment of pulmonary arterial hypertension: time to redefine success. Chest 2006; 130: 1198-1202.
5. Rich S, McLaughlin VV: Endothelin receptor blockers in cardiovascular disease. Circulation 2003; 108: 2184-2190.
6. Molenaar P, O'Reilly G, Sharkey A, et al: Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 1993; 72: 526-538.
7. Altiere RJ, Olson JW, Gillespie MN: Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension. J Pharmacol Exp Ther 1986; 236: 390-395.
8. Gariepy CE, Williams SC, Richardson JA, Hammer RE, Yanagisawa M: Transgenic expression of the endothelin-B receptor prevents congenital intestinal aganglionosis in a rat model of Hirschsprung disease. J Clin Invest 1998; 102: 1092-1101.
9. Ivy DD, Yanagisawa M, Gariepy CE, Gebb SA, Colvin KL, McMurtry IF: Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats. Am J Physiol Lung Cell Mol Physiol 2002; 282: L703-L712.
10. Cowan KN, Heilbut A, Humpl T, Lam C, Ito S, Rabinovitch M: Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 2000; 6: 698-702.
11. Ivy D, McMurtry IF, Yanagisawa M, et al: Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol 2001; 280: L1040-L1048.
12. Ivy DD, McMurtry IF, Colvin K, et al: Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension. Circulation 2005; 111: 2988-2996.